A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective StudySara Gagno, Giuseppe Toffoli, Fabio Puglisi et al.|Clinical Breast Cancer|2018Cited by 10
Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LARLibuse Tauchmanovà, Alma Contegiacomo, Matilde Pensabene et al.|Journal of Endocrinological Investigation|2005Cited by 3